Integrin Receptor Antagonists

Integrin Receptor Antagonist

Colitis, Ulcerative

Crohn Disease

Enteritis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Vedolizumab, an integrin receptor antagonist, is a humanized IgG<span class="Sub">1 </span>monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.</p><div class="Section" data-sectioncode="42229-5"><a name="section-9.1"></a><p></p><p class="First"><span class="Italics Underline">Intravenous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion. After reconstitution with 4.8 mL Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP, the resulting concentration is 60 mg/mL with a deliverable volume of 5 mL (300 mg) and the resulting pH is approximately 6.3.</p><p>Each single-dose vial contains 300 mg vedolizumab, arginine hydrochloride (131.7 mg), histidine (23 mg), histidine monohydrochloride (21.4 mg), polysorbate 80 (3 mg), and sucrose (500 mg).</p></div><div class="Section" data-sectioncode="42229-5"><a name="section-9.2"></a><p></p><p class="First"><span class="Italics Underline">Subcutaneous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) injection is supplied as a sterile, clear to moderately opalescent, colorless to slightly yellow, preservative-free solution for subcutaneous administration.</p><p>Each single-dose prefilled syringe or single-dose prefilled pen (ENTYVIO PEN) contains 108 mg vedolizumab, arginine hydrochloride (17.77 mg), citric acid monohydrate (0.18 mg), histidine (3.86 mg), histidine monohydrochloride (1.86 mg), polysorbate 80 (1.35 mg), sodium citrate dihydrate (4.71 mg) and Sterile Water for Injection, USP, at a pH of 6.5.</p></div></section>

Entyvio

vedolizumab

vedolizumab 300 MG Injection

vedolizumab 300 MG Injection [Entyvio]

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]

0.68 ML vedolizumab 159 MG/ML Auto-Injector

0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]

OConnor Hospital Outpatient Pharmacy

Actemra

Alecensa

Alunbrig

Aranesp

Ayvakit

Benlysta

Cabometyx

Cometriq

Cotellic

Enbrel

Erivedge

Erleada

Esbriet

Fasenra

Firazyr

Fotivda

Gilotrif

Idhifa

Inqovi

Inrebic

Iressa

Jakafi

Koselugo

Lenvima

Lonsurf

Lumakras

Lynparza

Mavenclad

Mekinest

Mektovi

Nerlynx

Naxavar

Nubeqa

Odomzo

Ofev

Retacrit

Rubraca

Siliq

Stelara

Stivarga

Tafinlar

Tagrisso

Tarceva

Targretin

Tykerb

Vitravki

Votrient

Xospata

Xpovio

Xtandi

Yonsa

Zelboraf

Zeposia

Zydelig

Entyvio | OConnor Hospital Outpatient Pharmacy

Which health plans does OConnor Hospital Outpatient Pharmacy have contracts with?

Does OConnor Hospital Outpatient Pharmacy work closely with Entyvio and Takeda Pharmaceuticals America, Inc.?

Does OConnor Hospital Outpatient Pharmacy offer services for Entyvio patients?

What conditions does OConnor Hospital Outpatient Pharmacy support?

How does OConnor Hospital Outpatient Pharmacy help with insurance?